Press Releases
KLIFO Receives Regulatory Approval for New State-of-the-Art Clinical Trial Supply Facility in Copenhagen
KLIFO Receives Regulatory Approval for New State-of-the-Art Clinical Trial Supply Facility in Copenhagen
Copenhagen, Denmark – 8 October 2025 – KLIFO, Europe’s largest independent provider of Clinical Trial Supply (CTS) packaging and distribution services, has announced that its new 6,500 sqm (65,000 sq ft) Abildager facility, in Copenhagen, has received official Manufacturing and Importation Authorisation from the Danish Medicines Agency.
This authorisation marks a significant milestone in KLIFO’s continued growth and its commitment to delivering innovative, flexible, and sustainable CTS solutions for the pharmaceutical and biotech industries.
The purpose-built facility is designed to meet the increasing demand for advanced clinical trial supply services and includes:
Significantly expanded capacity to support small-scale studies through to global Phase III and post-marketing trials
Comprehensive temperature management from controlled room temperature to -80°C for storage, primary and secondary packaging, and distribution
Low-light capabilities for light-sensitive products.
"Approval of our new facility represents a major step forward for KLIFO, and the site has already attracted significant interest from Nordic and international clients, reinforcing Copenhagen’s position as a leading life science hub in Europe," said René Pedersen, CEO, KLIFO.
"We can now offer even greater capacity to meet complex clinical trial supply chain needs globally while maintaining our focus on quality, compliance, and flexibility."
The new facility, combined with KLIFO’s experienced team, growing international reach, highly flexible solutions, and compliance with global requirements, means that KLIFO can accelerate project setup, reduce turnaround times, and minimise clinical supply chain issues.
About KLIFO
KLIFO is an integrated drug development clinical supply trial services provider and consultancy with more than 30 years of expertise in offering end-to-end solutions across all drug development areas through our Advisory and CTS business areas.
KLIFO CTS is the largest independent provider of end-to-end clinical trial supply services in Europe, offering proactive management throughout the clinical supply and logistics process.
KLIFO Advisory is an integrated North European drug development consultancy with significant experience in partnering with biotech, biopharma, and pharmaceutical companies, offering end-to-end solutions across all drug development areas.
For further information:
fiona.whyatt@ramarketingpr.com
